Found: 46
Select item for more details and to access through your institution.
Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Oncologist, 2013, v. 18, n. 11, p. 1214, doi. 10.1634/theoncologist.2013-0168
- By:
- Publication type:
- Article
Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
- Published in:
- Histopathology, 2024, v. 84, n. 7, p. 1224, doi. 10.1111/his.15168
- By:
- Publication type:
- Article
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions.
- Published in:
- CA: A Cancer Journal for Clinicians, 2021, v. 71, n. 2, p. 176, doi. 10.3322/caac.21650
- By:
- Publication type:
- Article
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3501, doi. 10.3390/cancers13143501
- By:
- Publication type:
- Article
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. e984, doi. 10.1093/oncolo/oyae028
- By:
- Publication type:
- Article
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes with Targeted Therapies in Real-World Cases of Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. e171, doi. 10.1093/oncolo/oyac265
- By:
- Publication type:
- Article
Real-World Comprehensive Genomic Profiling Success Rates in Tissue and Liquid Prostate Carcinoma Specimens.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. e970, doi. 10.1093/oncolo/oyac181
- By:
- Publication type:
- Article
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 787, doi. 10.1002/onco.13844
- By:
- Publication type:
- Article
State of the Science and Future Directions for Liquid Biopsies in Drug Development.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. 730, doi. 10.1634/theoncologist.2020-0246
- By:
- Publication type:
- Article
“Pulsatile” high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 12, p. 1364, doi. 10.1093/neuonc/nor121
- By:
- Publication type:
- Article
Activity of erlotinib when dosed below the maximum tolerated dose for EGFR-mutant lung cancer: Implications for targeted therapy development.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2570, doi. 10.1002/cncr.29397
- By:
- Publication type:
- Article
Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 15, p. 2289, doi. 10.1002/cncr.28723
- By:
- Publication type:
- Article
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00429-1
- By:
- Publication type:
- Article
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00429-1
- By:
- Publication type:
- Article
Genomic landscape of 891 RET fusions detected across diverse solid tumor types.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00347-2
- By:
- Publication type:
- Article
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00334-z
- By:
- Publication type:
- Article
Phase Ib Study of High-dose Intermittent Afatinib in Patients With Advanced Solid Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35245-x
- By:
- Publication type:
- Article
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33210-2
- By:
- Publication type:
- Article
Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR.
- Published in:
- PLoS ONE, 2022, p. 1, doi. 10.1371/journal.pone.0264201
- By:
- Publication type:
- Article
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer.
- Published in:
- Prostate, 2022, v. 82, n. 7, p. 867, doi. 10.1002/pros.24331
- By:
- Publication type:
- Article
Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial.
- Published in:
- European Radiology, 2021, v. 31, n. 4, p. 1853, doi. 10.1007/s00330-020-07249-y
- By:
- Publication type:
- Article
Realizing the Potential of Plasma Genotyping in an Age of Genotype-Directed Therapies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 8, p. 1, doi. 10.1093/jnci/dju214
- By:
- Publication type:
- Article
Germline Mutations in Driver Oncogenes and Inherited Lung Cancer Risk Independent of Smoking History.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 20, p. 1534, doi. 10.1093/jnci/djs353
- By:
- Publication type:
- Article
Measurement of mesothelioma on thoracic CT scans: A comparison of manual and computer-assisted techniques.
- Published in:
- Medical Physics, 2004, v. 31, n. 5, p. 1105
- By:
- Publication type:
- Article
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 24, p. 4557, doi. 10.1002/cncr.33865
- By:
- Publication type:
- Article
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2252244, doi. 10.1001/jamanetworkopen.2022.52244
- By:
- Publication type:
- Article
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e225394, doi. 10.1001/jamanetworkopen.2022.5394
- By:
- Publication type:
- Article
Prevalence of UV Mutational Signatures Among Cutaneous Primary Tumors.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e223833, doi. 10.1001/jamanetworkopen.2022.3833
- By:
- Publication type:
- Article
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.
- Published in:
- Nature Medicine, 2015, v. 21, n. 6, p. 560, doi. 10.1038/nm.3854
- By:
- Publication type:
- Article
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 216, p. 1, doi. 10.1126/scitranslmed.3007205
- By:
- Publication type:
- Article
False-Positive Rate of Posttherapy Positron Emission Tomography in Cervical Cancer.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Osimertinib for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC: Tolerability and Diagnostic Methods From an Expanded Access Program.
- Published in:
- Oncology & Therapy, 2018, v. 6, n. 1, p. 45, doi. 10.1007/s40487-018-0061-y
- By:
- Publication type:
- Article
Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 90, p. 1, doi. 10.1126/scitranslmed.3002356
- By:
- Publication type:
- Article
Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 2, p. 298, doi. 10.1002/1878-0261.13349
- By:
- Publication type:
- Article
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 27, doi. 10.1002/1878-0261.12673
- By:
- Publication type:
- Article
Savolitinib ± Osimertinib in Japanese Patients with Advanced Solid Malignancies or EGFRm NSCLC: Ph1b TATTON Part C.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Corrigendum: Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC.
- Published in:
- Scientific Reports, 2017, p. 41197, doi. 10.1038/srep41197
- By:
- Publication type:
- Article
Method of Tissue Acquisition Affects Success of Comprehensive Genomic Profiling in Lung Cancer.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2023, v. 147, n. 3, p. 338, doi. 10.5858/arpa.2021-0313-OA
- By:
- Publication type:
- Article
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2018, v. 142, n. 10, p. 1242, doi. 10.5858/arpa.2018-0901-SA
- By:
- Publication type:
- Article
Strategies for Overcoming Acquired Resistance to Epidermal Growth Factor Receptor-Targeted Therapies in Lung Cancer.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2012, v. 136, n. 10, p. 1205, doi. 10.5858/arpa.2012-0254-RA
- By:
- Publication type:
- Article
Commentary.
- Published in:
- Clinical Chemistry, 2015, v. 61, n. 4, p. 586, doi. 10.1373/clinchem.2014.234484
- By:
- Publication type:
- Article
A 78-Year-Old Woman with Brain Metastases.
- Published in:
- Clinical Chemistry, 2015, v. 61, n. 4, p. 584, doi. 10.1373/clinchem.2014.229864
- By:
- Publication type:
- Article